2021
Test, trace, and isolate in the UK
Cheng HY, Cohen T, Lin HH. Test, trace, and isolate in the UK. The BMJ 2021, 372: n822. PMID: 33789886, DOI: 10.1136/bmj.n822.Peer-Reviewed Original Research
2020
Ongoing challenges to understanding multidrug- and rifampicin-resistant tuberculosis in children versus adults
McQuaid CF, Cohen T, Dean AS, Houben RMGJ, Knight GM, Zignol M, White RG. Ongoing challenges to understanding multidrug- and rifampicin-resistant tuberculosis in children versus adults. European Respiratory Journal 2020, 57: 2002504. PMID: 32855219, DOI: 10.1183/13993003.02504-2020.Peer-Reviewed Original ResearchConceptsMDR/RR-TBRR-TBOdds ratioPediatric TB casesGlobal TB epidemicRifampicin-resistant tuberculosisPopulation-representative surveyTB casesBurden countriesTB epidemicMost settingsTuberculosisDrug resistanceTransmission riskCountry-specific estimatesAdultsChildrenAgeFurther investigationMultidrugOddsFormer Soviet Union countriesSufficient dataSettingSoviet Union countries
2013
Treatment outcome of multi-drug resistant tuberculosis in the United Kingdom: retrospective-prospective cohort study from 2004 to 2007.
Anderson LF, Tamne S, Watson JP, Cohen T, Mitnick C, Brown T, Drobniewski F, Abubakar I. Treatment outcome of multi-drug resistant tuberculosis in the United Kingdom: retrospective-prospective cohort study from 2004 to 2007. Eurosurveillance 2013, 18 PMID: 24128699, DOI: 10.2807/1560-7917.es2013.18.40.20601.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAntibiotics, AntitubercularAntitubercular AgentsChildChild, PreschoolDrug Resistance, Multiple, BacterialFemaleFluoroquinolonesHumansInfantInfant, NewbornMaleMicrobial Sensitivity TestsMiddle AgedMycobacterium tuberculosisPatient ComplianceProspective StudiesRetrospective StudiesSurveys and QuestionnairesTreatment OutcomeTuberculosis, Multidrug-ResistantUnited KingdomYoung AdultConceptsMultidrug-resistant tuberculosisTreatment outcomesRetrospective-prospective cohort studyWorld Health Organization targetMulti-drug resistant tuberculosisMDR-TB patientsMDR-TB treatmentMDR-TB casesFurther drug resistanceTreatment completion ratesSuccessful treatment outcomeUnited Kingdom guidelinesIndividualised regimensCohort studyMonths treatmentResistant tuberculosisTreatment completionInfectious casesDrug resistanceDrug sensitivitySuccessful outcomeOrganization targetBacteriostatic drugsOutcomesTreatment
2012
The dynamics of sexual contact networks: Effects on disease spread and control
Robinson K, Cohen T, Colijn C. The dynamics of sexual contact networks: Effects on disease spread and control. Theoretical Population Biology 2012, 81: 89-96. PMID: 22248701, PMCID: PMC3328800, DOI: 10.1016/j.tpb.2011.12.009.Peer-Reviewed Original ResearchConceptsDuration of infectiousnessHigh-activity individualsBehavioral interventionsBehavioral risk factorsControl of STDsHigh-risk individualsDifferent risk groupsWidespread screening programsHigh-risk subpopulationsPopulation-wide interventionsSexual network structureIndividual-level riskRisk factorsRisk groupsScreening programRisk subpopulationsGreater relative decreaseDynamics of transmissionSexual contactSexual partnershipsBiomedical interventionsInfectiousnessLonger durationComparable benefitsIntervention
2009
Use of Cumulative Incidence of Novel Influenza A/H1N1 in Foreign Travelers to Estimate Lower Bounds on Cumulative Incidence in Mexico
Lipsitch M, Lajous M, O'Hagan JJ, Cohen T, Miller JC, Goldstein E, Danon L, Wallinga J, Riley S, Dowell SF, Reed C, McCarron M. Use of Cumulative Incidence of Novel Influenza A/H1N1 in Foreign Travelers to Estimate Lower Bounds on Cumulative Incidence in Mexico. PLOS ONE 2009, 4: e6895. PMID: 19742302, PMCID: PMC2731883, DOI: 10.1371/journal.pone.0006895.Peer-Reviewed Original ResearchConceptsInfluenza A/H1N1Influenza A/Cumulative incidenceNovel influenza A/Severity of illnessSeverity of diseaseSevere diseaseTotal numberSevere symptomsNumber of casesDisease severityCurrent epidemicInfectious diseasesCanadian travellersIncidenceDiseaseAffected individualsSeverityH1N1Mexican residentsObserved groupEpidemicNovel pathogensDisease spreadResidents